The incidence of postoperative re-stratification for recurrence in well-differentiated thyroid cancer-a retrospective cohort study

被引:2
|
作者
Neiderman, Narin N. Carmel [1 ]
Duek, Irit [1 ]
Ravia, Adi [1 ]
Yaka, Ronel [1 ]
Warshavsky, Anton [1 ]
Ringel, Barak [1 ]
Muhanna, Nidal [1 ]
Horowitz, Gilad [1 ]
Baran, Tomer Ziv [2 ]
Fliss, Dan M. [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck,Maxillofacial Surg, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel
关键词
Low risk; risk stratification; partial thyroidectomy; hemi-thyroidectomy (HT); completion thyroidectomy; ASSOCIATION MANAGEMENT GUIDELINES; LOW-RISK; HORMONE REPLACEMENT; ADULT PATIENTS; PAPILLARY; CARCINOMA; EXTENT; LOBECTOMY; SURVIVAL; FEATURES;
D O I
10.21037/gs-21-105
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: After diagnosing well-differentiated thyroid cancer (WDTC), assessment of the risk for disease-specific recurrence is essential for deciding between hemi-thyroidectomy (HT) and total thyroidectomy (TT). The American Thyroid Association (ATA) 2015 guidelines suggest that patients with 1-4 cm WDTC without suspicious features may be suitable for HT. Patients' preoperatively determined risk levels are re-stratified according to surgical and final histopathological findings. The incidence and clinical implications of high-risk features discovered postoperatively in patients with preoperatively determined low-risk WDTC are yet to be better defined. Methods: Thyroidectomies performed in the Tel-Aviv Sourasky Medical Center (TASMC) [2006-2018] were included. Patients with 1-4 cm WDTC without evidence of positive cervical lymph nodes, invasion to adjacent structures, or high-risk cytology were considered at low risk for disease-specific recurrence-suitable for lobectomy. Patients were stratified according to their risk for disease-specific recurrence, pre- and postoperatively, and the rate of completion thyroidectomy was determined. Results: In total, 301 (21%) patients were preoperatively stratified as low risk. Forty-six of them (15%) were re-stratified postoperatively as intermediate-to-high-risk. There were no significant differences in the characteristics of the patients who maintained their original stratification to patients who were upscaled to a higher risk level postoperatively. Conclusions: We report a 15% rate of postoperative risk escalation of patients who required completion thyroidectomy according to current ATA guidelines. In our opinion, this rate of postoperative WDTC upscaling of risk requiring more radical surgery than originally planned, is acceptable. Meticulous preoperative personalized evaluation by an experienced multidisciplinary dedicated team is essential.
引用
收藏
页码:2354 / 2367
页数:14
相关论文
共 50 条
  • [1] Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study
    Khan, Usman
    Al Afif, Ayham
    Aldaihani, Abdullah
    MacKay, Colin
    Rigby, Matthew H.
    Rajaraman, Murali
    Imran, Syed Ali
    Bullock, Martin J.
    Taylor, S. Mark
    Trites, Jonathan R. B.
    Hart, Robert D.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 49 (01)
  • [2] Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis
    Muller, S.
    Senne, M.
    Kirschniak, A.
    Koenigsrainer, A.
    Bares, R.
    Falch, C.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15 : 190
  • [3] Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer
    Chan, Samuel
    Karamali, Katarina
    Kolodziejczyk, Anna
    Oikonomou, Georgios
    Watkinson, John
    Paleri, Vinidh
    Nixon, Iain
    Kim, Dae
    EUROPEAN THYROID JOURNAL, 2020, 9 (02) : 73 - 84
  • [4] Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer
    Lo, Tom Edward Ngo
    Canto, Abigail Uy
    Maningat, Patricia Deanna D.
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (04) : 543 - 550
  • [5] Completion thyroidectomy of well-differentiated thyroid cancer - a prospective, miserandomised study
    Proczko, Monika
    Stefaniak, Tomasz
    Sworczak, Krzysztof
    Kobiela, Jaroslaw
    Lachinski, Andrzej Jacek
    Stepaniak, Pieter
    Sledzinski, Zbigniew
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (05) : 335 - 339
  • [6] The age factor in survival of a population cohort of well-differentiated thyroid cancer
    Mazurat, Andrea
    Torroni, Andrea
    Hendrickson-Rebizant, Jane
    Benning, Harbinder
    Nason, Richard W.
    Pathak, K. Alok
    ENDOCRINE CONNECTIONS, 2013, 2 (03):
  • [7] Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer
    Yang, Xue
    Liang, Jun
    Li, Tian-Jun
    Yang, Ke
    Liang, Dong-Quan
    Yu, Zhuang
    Lin, Yan-Song
    CHINESE MEDICAL JOURNAL, 2015, 128 (08) : 1058 - 1064
  • [8] Postoperative hypoparathyroidism after completion thyroidectomy for well-differentiated thyroid cancer
    Giordano, Davide
    Botti, Cecilia
    Piana, Simonetta
    Zini, Michele
    Frasoldati, Andrea
    Lusetti, Francesca
    Cavuto, Silvio
    Savoldi, Luisa
    Pernice, Carmine
    Ghidini, Angelo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (03) : 413 - 419
  • [9] Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation?
    Adilbay, Dauren
    Yuan, Avery
    Romesser, Paul B.
    Wong, Richard J.
    Shah, Jatin P.
    Shaha, Ashok R.
    Tuttle, Michael R.
    Patel, Snehal
    Lee, Nancy Y.
    Ganly, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5582 - 5590
  • [10] DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
    Mancikova, Veronika
    Buj, Raquel
    Castelblanco, Esmeralda
    Inglada-Perez, Lucia
    Diez, Anna
    de Cubas, Aguirre A.
    Curras-Freixes, Maria
    Xavier Maravall, Francisco
    Mauricio, Didac
    Matias-Guiu, Xavier
    Puig-Domingo, Manel
    Capel, Ismael
    Rosa Bella, Maria
    Lerma, Enrique
    Castella, Eva
    Lluis Reverter, Jordi
    Angel Peinado, Miguel
    Jorda, Mireia
    Robledo, Mercedes
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (03) : 598 - 610